41 related articles for article (PubMed ID: 24064772)
1. MCT4 and CD147 colocalize with MMP14 in invadopodia and support matrix degradation and invasion by breast cancer cells.
Meng S; Sørensen EE; Ponniah M; Thorlacius-Ussing J; Crouigneau R; Larsen T; Borre MT; Willumsen N; Flinck M; Pedersen SF
J Cell Sci; 2024 Apr; 137(8):. PubMed ID: 38661040
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal signature motif on the transporter MCT1 is critical for CD147-mediated trafficking.
Seka DJ; Schulz AK; Thaker TM; Tomasiak TM
J Biol Chem; 2024 May; 300(6):107333. PubMed ID: 38820650
[TBL] [Abstract][Full Text] [Related]
3. PPFIA4 Promotes Proliferation, Migration and Glycolysis of Esophageal Cancer Cells.
He Y; Lu D; Cheng H; Zhang Y; Wu F; Chen Z
Ann Clin Lab Sci; 2023 Nov; 53(6):840-846. PubMed ID: 38182152
[TBL] [Abstract][Full Text] [Related]
4. Correction: Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway.
Zhang N; Liu Z; Lai X; Liu S; Wang Y
Respir Res; 2024 Mar; 25(1):136. PubMed ID: 38515101
[No Abstract] [Full Text] [Related]
5. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
[TBL] [Abstract][Full Text] [Related]
6. Monocarboxylate transporters as targets and mediators in cancer therapy response.
Baltazar F; Pinheiro C; Morais-Santos F; Azevedo-Silva J; Queirós O; Preto A; Casal M
Histol Histopathol; 2014 Dec; 29(12):1511-24. PubMed ID: 24921258
[TBL] [Abstract][Full Text] [Related]
7. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
8. Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect.
Pereira-Nunes A; Afonso J; Granja S; Baltazar F
Adv Exp Med Biol; 2020; 1219():51-74. PubMed ID: 32130693
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells.
Zhang P; Ma J; Gao J; Liu F; Sun X; Fang F; Zhao S; Liu H
J Bioenerg Biomembr; 2018 Aug; 50(4):271-281. PubMed ID: 29882205
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma.
Xiao W; Zhao S; Shen F; Liang J; Chen J
Exp Ther Med; 2017 Sep; 14(3):2637-2642. PubMed ID: 28962206
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative Activity of Triterpene Glycoside Nutrient from Monk Fruit in Colorectal Cancer and Throat Cancer.
Liu C; Dai L; Liu Y; Rong L; Dou D; Sun Y; Ma L
Nutrients; 2016 Jun; 8(6):. PubMed ID: 27304964
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
[TBL] [Abstract][Full Text] [Related]
13. Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland.
Mauris J; Dieckow J; Schob S; Pulli B; Hatton MP; Jeong S; Bauskar A; Gabison E; Nowak R; Argüeso P
Cell Death Dis; 2015 Apr; 6(4):e1726. PubMed ID: 25880093
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer.
Xu T; Zhou M; Peng L; Kong S; Miao R; Shi Y; Sheng H; Li L
Int J Clin Exp Pathol; 2014; 7(11):7432-41. PubMed ID: 25550778
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CD147 by chitooligosaccharide inhibits MMP-2 expression and suppresses the metastatic potential of human gastric cancer.
Luo Z; Dong X; Ke Q; Duan Q; Shen L
Oncol Lett; 2014 Jul; 8(1):361-366. PubMed ID: 24959277
[TBL] [Abstract][Full Text] [Related]
16. EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.
Sangboonruang S; Thammasit P; Intasai N; Kasinrerk W; Tayapiwatana C; Tragoolpua K
Cancer Gene Ther; 2014 Jun; 21(6):246-55. PubMed ID: 24924201
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo.
Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S
Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772
[TBL] [Abstract][Full Text] [Related]
18. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
